wire - news in brief


Category


Years
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008

Last News


Results 101 - 150 of 285.

Event - Arts and Design
16.11.2016
SNSF launches scientific image competition in Switzerland
SNSF launches scientific image competition in Switzerland
The Swiss National Science Foundation is launching a competition for scientific images and videos. Open to researchers working in Switzerland, the competition aims to reveal the hidden beauty of science.
Medicine/Pharmacology - Life Sciences
16.11.2016
Novartis data at ASH and SABCS showcase latest innovations in development for patients with blood disorders and breast cancer
First results from global registrational trial of CAR T'therapy, CTL019, in pediatric relapsed/refractory acute lymphoblastic leukemia  Sub-group analyses from pivotal MONALEESA-2 trial of LEE011 (ri
Medicine/Pharmacology - Physics/Materials Science
16.11.2016
Novartis announces AMG 334 significantly reduces monthly migraine days in second pivotal Phase III episodic migraine study
STRIVE, the first six-month placebo-controlled study of AMG 334 (erenumab) in migraine, met the primary endpoint, showing a statistically significant reduction in monthly migraine days versus placebo
Medicine/Pharmacology
15.11.2016
New analysis of Novartis’ Entresto data shows long-term benefits on heart failure readmissions and total cardiovascular deaths
Entresto reduced the risk of first and subsequent events of heart failure hospitalizations and cardiovascular deaths following heart failure hospitalization by 20%-24% compared to enalapril   These f
Life Sciences - Medicine/Pharmacology
15.11.2016
Drosophila innate immunity: another piece to the puzzle
Drosophila innate immunity: another piece to the puzzle
EPFL scientists have discovered a new receptor in the fruit fly immune system that detects bacterial infections. The finding opens up clues for our own immune responses. Our immune system has two phases: innate and adaptive. The first phase, innate, refers to the immediate defense mechanisms such as skin, blood chemicals and certain types of immune cells that constantly fight off foreign organisms to keep them from infecting us.
Medicine/Pharmacology - Life Sciences
15.11.2016
Roche launches imCORE, a global network of cancer immunotherapy centers of excellence
Roche launches imCORE, a global network of cancer immunotherapy centers of excellence Research network of 21 academic centers from around the world to access and share technology, data and expertise
Physics/Materials Science - Event
14.11.2016
Medicine/Pharmacology - Administration/Government
14.11.2016
Novartis presents new Cosentyx data showing long-lasting efficacy in psoriatic arthritis over 3 years including patient-reported pain
Cosentyx data show sustained improvements in the signs and symptoms of psoriatic arthritis (PsA) in approximately 80% of patients over 3 years *   New data show that with Cosentyx the high ACR response rates are consistently maintained in PsA, with no reduction from Year 1 to Year 3   New head-to-head clinical trials planned in ankylosing spondylitis (AS) and PsA to compare Cosentyx versus Humira **/*** The digital press release with multimedia
Medicine/Pharmacology - Media
14.11.2016
Novartis drug PKC412 (midostaurin) granted FDA Priority Review for newly-diagnosed FLT3-mutated AML and advanced systemic mastocytosis
Priority Review based on data from the largest clinical trials conducted to date in each indication , Designation will shorten FDA expected review time to within six months ; EMA also accepted the PK
Medicine/Pharmacology
14.11.2016
Novartis improves ranking in 2016 Access to Medicine Index
Novartis ranks third in 2016 ranking   Company tops the industry in access-to-medicine management and capacity building   Novartis integrated access strategy addressing all income segments stands out
Agronomy/Food Science - Life Sciences
10.11.2016
Vacancies on Agroscope Executive Board all filled: Alain Gaume as Head of ‘Plant Pro-tection’
Bern, 10.11.2016 - Dr. Alain Gaume will be the new Head of Agroscope's ‘Plant Protection' Strategic Research Division.
Medicine/Pharmacology
10.11.2016
Reducing Childhood Diarrhoea by Integrated Home-Based Interventions
A combination of better indoor air, clean drinking water and improved hygiene in Peruvian households reduces the prevalence of childhood diarrhoea by 29% according to a community randomised trial conducted by the Swiss Tropical and Public Health Institute (Swiss TPH) and the Instituto de Investigación Nutricional (IIN).
Event - Chemistry
09.11.2016
Computer Science/Telecom - Microtechnics/Electroengineering
09.11.2016
Robotic encounters
Visitors are flocking to Treffpunkt Science City. Around 3,600 captivated visitors attended the Sunday Special ‘Die Roboter sind los' (Robots on the loose) to see ETH Zurich's various robotics projects in action.
Politics
08.11.2016
Swiss politics is increasingly dominated by an urban-rural divide
Swiss politics is increasingly dominated by an urban-rural divide
According to Koseki, Swiss people in the area stretching from Geneva to Bern and St. Gallen increasingly share interests.
Event
07.11.2016
EPFL's Open Days: a major success
EPFL's Open Days: a major success
Close to 35,000 people took advantage of EPFL's Open Days this past weekend to visit the school's campus, where the new ArtLab building also just opened.
Mechanical Engineering/Mechanics
06.11.2016
A pioneer in advanced engine research
Rolf Reitz is a pioneer when it comes to internal combustion engines. The foundations he has laid have led to cleaner, more efficient engines.
Architecture - Medicine/Pharmacology
04.11.2016
An opportunity for the university district and ETH Zurich
An opportunity for the university district and ETH Zurich
Zurich's central university district continues to take shape. A joint press conference was held today by the canton and city of Zurich, University Hospital, the University of Zurich and ETH Zurich to provide information on the planning status.
Business/Economics
04.11.2016
Switzerland intensifies relations with Mexico
Bern, 04.11.2016 - President Johann N. Schneider-Ammann has paid a two-day presidential visit to Mexico.
Medicine/Pharmacology - Life Sciences
03.11.2016
Roche showcases new clinical data across a variety of blood diseases at American Society of Hematology 2016 Annual Meeting
Roche showcases new clinical data across a variety of blood diseases at American Society of Hematology 2016 Annual Meeting New results from the phase III GALLIUM study which compared Gazyva/Gazyvaro
Life Sciences - Medicine/Pharmacology
03.11.2016
How the liver dances to a day/night rhythm
How the liver dances to a day/night rhythm
Following the day-night cycle, the liver has its own metabolic rhythm. Using cutting-edge proteomics, scientists at EPFL and Nestlé Institute of Health Sciences have now identified over 500 liver proteins that change in abundance over the course of the day in the cell nucleus, opening a new dimension of metabolism.
Medicine/Pharmacology
03.11.2016
Neglected tropical diseases: scientists bridge the gap between innovation and practice
Clinical innovation is essential in order to tackle neglected tropical diseases, which threaten one billion people worldwide. A group of international scientists has published a guide for clinical studies in difficult field circumstances in PLOS Neglected Tropical Diseases. NIDIAG is an EU-funded consortium of scientists from 13 institutes including Swiss TPH and universities in Europe, Africa and Asia.
Arts and Design - Architecture
03.11.2016
Life Sciences - Medicine/Pharmacology
03.11.2016
Award for innovative cell culture technology
Award for innovative cell culture technology
Researchers at ETH Zurich have developed a new cell culture method, which may very well enable to forgo certain tests on animals in the future.
Life Sciences - Chemistry
02.11.2016
Chemists Create Clusters of Organelles by Mimicking Nature
Chemists Create Clusters of Organelles by Mimicking Nature
Scientists from the University of Basel have succeeded in organizing spherical compartments into clusters mimicking the way natural organelles would create complex structures.
Medicine/Pharmacology - Life Sciences
02.11.2016
Roche to present new data on medicines for autoimmune diseases and severe inflammatory disorders at the 2016 ACR/ARHP Annual Meeting
Roche to present new data on medicines for autoimmune diseases and severe inflammatory disorders at the 2016 ACR/ARHP Annual Meeting 15 oral presentations from 17 abstracts across six autoimmune cond
Medicine/Pharmacology - Life Sciences
01.11.2016
Novartis LEE011 (ribociclib) granted FDA Priority Review for first-line treatment of HR+/HER2- advanced breast cancer
Priority Review based on Phase III MONALEESA-2 trial, which showed LEE011 plus letrozole, as initial treatment for advanced breast cancer, significantly extended progression-free survival compared to
Medicine/Pharmacology
01.11.2016
Being fit Protects Against Health Risks Caused by Stress at Work
Being fit Protects Against Health Risks Caused by Stress at Work
It is a well-known fact that fitness and well-being go hand in hand. But being in good shape also protects against the health problems that arise when we feel particularly stressed at work. As reported by sports scientists from the University of Basel and colleagues from Sweden, it therefore pays to stay physically active, especially during periods of high stress.
Civil Engineering/Traffic Engineering - Environment/Sustainable Development
01.11.2016
Preserve the Alps by giving up the chalets
Preserve the Alps by giving up the chalets
An isolated chalet in the mountains is a dream for nature lovers. However, this dream is responsible for most of the problems that winter resorts face today.
Medicine/Pharmacology - Event
31.10.2016
Novartis Wins Two Prestigious Prix Galien Foundation Awards; Gleevec recognized as "Discovery of the Decade" for Best Pharmaceutical Product, Cosentyx as Best Biotechnology Product
Novartis Wins Two Prestigious Prix Galien Foundation Awards; Gleevec recognized as "Discovery of the Decade" for Best Pharmaceutical Product, Cosentyx as Best Biotechnology Product Basel, October 31,
Chemistry - Earth Sciences
31.10.2016
Cadmium, cocoa beans and chocolate
Cadmium, cocoa beans and chocolate
Cocoa from Latin America tends to show higher cadmium levels than cocoa from other growing areas. ETH researchers have been investigating the underlying cause in Honduras and Bolivia. A few years ago, the press picked up on worrying reports by German scientists that dark chocolate can sometimes contain significant amounts of cadmium, a poisonous heavy metal.
Life Sciences - Medicine/Pharmacology
28.10.2016
Bernese Biotechnology Has International Triumph
MRI data are essential in the treatment of neurological illnesses. Self-learning software from Bern respectively evaluates them so that the imaging of brain tumours, strokes and now also multiple sclerosis can profit from it.
Medicine/Pharmacology - Environment/Sustainable Development
28.10.2016
Medicine/Pharmacology
27.10.2016
ZikaPLAN: 25 Research Organisations to Fight Zika Virus
ZikaPLAN: Swiss TPH Unites with 25 Research Organizations to Fight Zika Virus and Build Long-term Outbreak Response Capacity in Latin America Swiss TPH is among the 25 leading research and public hea
Microtechnics/Electroengineering - Computer Science/Telecom
27.10.2016
A Composite Thread that Varies in Rigidity
A Composite Thread that Varies in Rigidity
EPFL scientists have developed a new type of composite thread that varies in stiffness depending on its temperature.
Astronomy - Physics/Materials Science
27.10.2016
Finally red!
Finally red!
Empa researchers have pulled off a masterstroke of ceramics research: as of now, a dark-red ceramic bezel adorns a Swiss luxury watch - a world premiere and stunning example of top-flight materials science.
Chemistry - Physics/Materials Science
27.10.2016
The substances that brighten up the clouds
The substances that brighten up the clouds
Clouds consist of tiny droplets. These droplets form when water condenses around so-called aerosols – small particles in the atmosphere. How in turn aerosols come into existence is hence vital for understanding cloud brightness and thus climate and climate change. In a research collaboration with participants at the University of Leeds, at CERN, at the Paul Scherrer Institute PSI and numerous other scientific institutions around the world, scientists have now created a comprehensive computer model simulation based on profound experimental data.
Computer Science/Telecom - Microtechnics/Electroengineering
26.10.2016
Welcome to the World 4.0!
Welcome to the World 4.0!
Self-driving cars, talking robots and intelligent houses: the autumn edition of the Treffpunkt Science City series begins next Sunday and will focus on everyday life in the World 4.0.
Environment/Sustainable Development
26.10.2016
Measuring air quality at Beromünster
Measuring air quality at Beromünster
A new measurement station for air pollution monitoring has been opened in Beromünster, Canton Lucerne, the first since 1990. The measurement station, operated by Empa and the Swiss Federal Office for the Environment is located on the site of the former international radio transmitter and monitors air pollution in the rural area of the Swiss Plateau.
Careers/Employment - Business/Economics
26.10.2016
A 10 million euro round of financing for the start up Coorpacademy
A 10 million euro round of financing for the start up Coorpacademy
Coorpacademy, a startup based in EPFL's Innovation Park, has completed a 10 million euro round of financing.
Administration/Government
25.10.2016
Scientific cooperation between Switzerland and Australia
Bern, 25.10.2016 - The second meeting of the Swiss-Australian joint committee for cooperation in the areas of science, research and cooperation was held today in Bern.
Business/Economics - Medicine/Pharmacology
25.10.2016
Novartis delivered solid third quarter with Growth Products[1] offsetting Gleevec patent expiration; several positive readouts for potential blockbusters
Novartis delivered solid third quarter with Growth Products[1] offsetting Gleevec patent expiration; several positive readouts for potential blockbusters
Novartis delivered solid third quarter with Growth Products offsetting Gleevec patent expiration; several positive readouts for potential blockbusters Q3 net sales (-1% cc and USD) broadly in line wit
Physics/Materials Science
24.10.2016
Under the chemical microscope
Under the chemical microscope
with Daniel Grolimund At the Swiss Light Source SLS, researcher Daniel Grolimund is responsible for a beamline where the arrangement of chemical bonds in different objects can be determined. These capabilities prove valuable to researchers in the most diverse disciplines: to battery researchers as well as biologists, archeologists, and many more.
Earth Sciences - Astronomy
24.10.2016
Swiss Researchers Fly Into Weightlessness
The dream of weightlessness came true on Saturday for two researchers from the University of Basel. During a parabolic flight, the scientists tested a newly developed measuring device under reduced gravity. The instrument analyzes the deposition of sediments and is intended to support the search for life on Mars.
Astronomy - Earth Sciences
21.10.2016
Second research flight into zero gravity
A year ago, the University of Zurich conducted its first parabolic flight for test purposes from Swiss soil. Now a second aircraft is ready for lift-off to research zero gravity: Tomorrow (Saturday), an Airbus A310 ZERO-G is set to take off from the air force base in Dübendorf equipped with scientific experiments from the Universities of Zurich, Basel, Lucerne and ETH Zurich.
Business/Economics
21.10.2016
Medicine/Pharmacology
21.10.2016
Inflammation Triggers Unsustainable Immune Response to Chronic Viral Infection
Inflammation Triggers Unsustainable Immune Response to Chronic Viral Infection
Scientists at the University of Basel discovered a fundamental new mechanism explaining the inadequate immune defense against chronic viral infection.
Medicine/Pharmacology - Life Sciences
19.10.2016
FDA approves Roche’s cancer immunotherapy TECENTRIQ (atezolizumab) for people with a specific type of metastatic lung cancer
FDA approves Roche's cancer immunotherapy TECENTRIQ (atezolizumab) for people with a specific type of metastatic lung cancer First and only anti-PD-L1 cancer immunotherapy approved by the FDA for met
Computer Science/Telecom - Environment/Sustainable Development
19.10.2016
Collaboration has never been as close as it is today?
Collaboration has never been as close as it is today?
This week, the Swiss National Computing Centre (CSCS) in Lugano celebrates its 25 th anniversary. Christoph Schär, ETH professor with the Institute for Atmospheric and Climate Science, was there from the very start.